Growth of Type 1 Neovascularization Following Cessation of Anti-Vascular Endothelial Growth Factor Therapy as a Possible Explanation for Treatment Resistance

被引:0
|
作者
Gallego-Pinazo, Roberto [1 ,2 ]
Shah, Vinnie [2 ]
Freund, K. Bailey [2 ,3 ]
机构
[1] Univ & Polytech Hosp La Fe, Ophthalmol, Valencia, Spain
[2] Vitreous Retina Macula Consultants New York, New York, NY USA
[3] NYU, Sch Med, Ophthalmol, New York, NY USA
关键词
453 choroid: neovascularization; 412 age-related macular degeneration; 461 clinical (human) or epidemiologic studies: natural history;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3807
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Growth of Type 1 Neovascularization Following Cessation of Anti-Vascular Endothelial Growth Factor Therapy as a Possible Explanation for Treatment Resistance
    Shah, Vinnie P.
    Freund, K. Bailey
    JAMA OPHTHALMOLOGY, 2013, 131 (07) : 967 - 969
  • [2] ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION
    Sudhalkar, Aditya
    Yogi, Rohit
    Chhablani, Jay
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (07): : 1368 - 1374
  • [3] Anti-vascular endothelial growth factor for myopic choroidal neovascularization
    Ng, Danny S.
    Kwok, Alvin K. H.
    Chan, Clement W.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 (01): : E98 - E110
  • [4] Vascular Endothelial Growth Factor Gene and the Response to Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in High Myopia
    Miyake, Masahiro
    Yamashiro, Kenji
    Akagi-Kurashige, Yumiko
    Kumagai, Kyoko
    Nakata, Isao
    Nakanishi, Hideo
    Oishi, Akio
    Tsujikawa, Akitaka
    Yamada, Ryo
    Matsuda, Fumihiko
    Yoshimura, Nagahisa
    OPHTHALMOLOGY, 2014, 121 (01) : 225 - 233
  • [5] Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization
    Kim, Jae Hui
    Chang, Young Suk
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Long Won
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (03) : 480 - 487
  • [6] Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization
    Jae Hui Kim
    Young Suk Chang
    Jong Woo Kim
    Chul Gu Kim
    Dong Won Lee
    International Journal of Ophthalmology, 2019, 12 (03) : 480 - 487
  • [7] Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
    Zina, Sourour
    Khochtali, Sana
    Invernizzi, Alessandro
    Ksiaa, Imen
    Hager, Ben Amor
    Viola, Francesco
    Abroug, Nesrine
    Khairallah, Moncef
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2021, 33 (01): : 68 - 74
  • [8] Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization
    Ahn, Seong Joon
    Park, Kyu Hyung
    Woo, Se Joon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (10) : 5794 - 5800
  • [9] Anti-vascular endothelial growth factor: the future treatment of choroidal neovascularization in pathologic myopia?
    Zhu Hong
    Wang Feng-hua
    Sun Xiao-dong
    CHINESE MEDICAL JOURNAL, 2013, 126 (08) : 1578 - 1583
  • [10] Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
    Ruparelia, Sunil
    Sundaram, Aishwarya
    Dahrab, Mishari
    Symonds, Chris
    Cruess, Alan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)